Debt-to-equity of PUMA BIOTECHNOLOGY, INC. from 31 Mar 2012 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
PUMA BIOTECHNOLOGY, INC. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 31 Dec 2025.
  • PUMA BIOTECHNOLOGY, INC. Debt-to-equity for the quarter ending 31 Dec 2025 was 81%, a 64% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

PUMA BIOTECHNOLOGY, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 81% -144% -64% 31 Dec 2025
Q3 2025 97% -191% -66% 30 Sep 2025
Q2 2025 126% -219% -63% 30 Jun 2025
Q1 2025 170% -219% -56% 31 Mar 2025
Q4 2024 225% -235% -51% 31 Dec 2024
Q3 2024 289% -317% -52% 30 Sep 2024
Q2 2024 345% -372% -52% 30 Jun 2024
Q1 2024 389% -418% -52% 31 Mar 2024
Q4 2023 460% -594% -56% 31 Dec 2023
Q3 2023 605% -1054% -64% 30 Sep 2023
Q2 2023 718% -5451% -88% 30 Jun 2023
Q1 2023 807% -3023% -79% 31 Mar 2023
Q4 2022 1054% -1841% -64% 31 Dec 2022
Q3 2022 1659% -1659% -50% 30 Sep 2022
Q2 2022 6169% +3669% +147% 30 Jun 2022
Q1 2022 3830% +845% +28% 31 Mar 2022
Q4 2021 2895% -779% -21% 31 Dec 2021
Q3 2021 3318% +1438% +76% 30 Sep 2021
Q2 2021 2500% +1182% +90% 30 Jun 2021
Q1 2021 2985% +1668% +127% 31 Mar 2021
Q4 2020 3673% +2734% +291% 31 Dec 2020
Q3 2020 1880% +1070% +132% 30 Sep 2020
Q2 2020 1318% +689% +109% 30 Jun 2020
Q1 2020 1317% +770% +141% 31 Mar 2020
Q4 2019 939% +535% +132% 31 Dec 2019
Q3 2019 810% +503% +164% 30 Sep 2019
Q2 2019 629% +403% +178% 30 Jun 2019
Q1 2019 547% +425% +347% 31 Mar 2019
Q4 2018 404% +329% +436% 31 Dec 2018
Q3 2018 307% +264% +615% 30 Sep 2018
Q2 2018 226% +194% +609% 30 Jun 2018
Q1 2018 122% +92% +308% 31 Mar 2018
Q4 2017 75% +47% +163% 31 Dec 2017
Q3 2017 43% +16% +57% 30 Sep 2017
Q2 2017 32% +12% +64% 30 Jun 2017
Q1 2017 30% +16% +108% 31 Mar 2017
Q4 2016 29% +17% +155% 31 Dec 2016
Q3 2016 27% +14% +101% 30 Sep 2016
Q2 2016 19% +3.8% +24% 30 Jun 2016
Q1 2016 14% -3.8% -21% 31 Mar 2016
Q4 2015 11% -9% -45% 31 Dec 2015
Q3 2015 14% -3.6% -21% 30 Sep 2015
Q2 2015 16% -1.1% -6.5% 30 Jun 2015
Q1 2015 18% +1% +6% 31 Mar 2015
Q4 2014 20% -0.61% -2.9% 31 Dec 2014
Q3 2014 17% -2.2% -11% 30 Sep 2014
Q2 2014 17% -9.1% -35% 30 Jun 2014
Q1 2014 17% -14% -45% 31 Mar 2014
Q4 2013 21% -16% -43% 31 Dec 2013
Q3 2013 19% -22% -53% 30 Sep 2013
Q2 2013 26% +3.4% +15% 30 Jun 2013
Q1 2013 31% +19% +162% 31 Mar 2013
Q4 2012 37% 31 Dec 2012
Q3 2012 41% 30 Sep 2012
Q2 2012 22% 30 Jun 2012
Q1 2012 12% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.